Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma: Results of a randomized Phase II study (European Orga... von FOSSA, Sophie D, MICKISCH, Gerald H. J, DE MULDER, Pieter H. M, HORENBLAS, Simon, VAN OOSTEROM, Allan T, VAN POPPEL, Hein, FEY, Martin, CROIES, Jelle J, DE PRIJCK, Linda, VAN GLABBEKE, Martine

Volltext

Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma von Fosså, Sophie D, Mickisch, Gerald H J, De Mulder, Pieter H M, Horenblas, Simon, van Oosterom, Allan T, van Poppel, Hein, Fey, Martin, Croles, Jelle J, de Prijck, Linda, Van Glabbeke, Martine

Volltext

Interferon‐α‐2a with or without 13‐cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma von Fosså, Sophie D., Mickisch, Gerald H. J., De Mulder, Pieter H. M., Horenblas, Simon, van Oosterom, Allan T., van Poppel, Hein, Fey, Martin, Croles, Jelle J., de Prijck, Linda, Van Glabbeke, Martine

Volltext

Continuous infusion of high‐dose 5‐fluorouracil in combination with leucovorin and recombinant interferon‐alpha‐2b in patients with advanced colorectal cancer. A multicenter phase... von Punt, Cornelis J. A., Burghouts, Jos Th. M., Croles, Jelle J., van Liessum, Peter A., de Mulder, Pieter H. M., Kamm, Yvonne

Volltext

Phase II trial of cisplatin for adenocarcinoma of unknown primary site von Wagener, D.J.Theo, de Mulder, Pieter H.M., Burghouts, Jos Th, Croles, Jelle J.

Volltext